These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35861631)

  • 21. New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies.
    Ghanaatpisheh A; Safari M; Haghshenas H; Motamed-Sanaye A; Atefi AH; Kamangarpour K; Bagherzadeh MA; Kamran-Jahromi A; Darayesh M; Kouhro N; Bahadori AR; Esfandiari MA
    Front Med (Lausanne); 2024; 11():1293920. PubMed ID: 38654835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.
    Singh R; Freeman EE
    Curr Dermatol Rep; 2022; 11(4):289-312. PubMed ID: 36274754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review.
    Alpalhão M; Maia-Silva J; Filipe P
    Dermatitis; 2021 May-Jun 01; 32(3):133-139. PubMed ID: 33851937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination.
    Shawky A; Elrewiny EM; Gharib K; Sallam M; Mansour M; Rageh MA
    Int J Dermatol; 2023 Feb; 62(2):221-224. PubMed ID: 35959522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
    Gronbeck C; Grant-Kels JM
    Clin Dermatol; 2021; 39(4):674-687. PubMed ID: 34809772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse reactions to coronavirus vaccines: A Saudi nationwide study.
    Bukhari AE; Almutlq MM; Bin Dakhil AA; Alhetheli GI; Alfouzan SK; Alqahtani MA; Aljalfan AA; Almutawa MA; Alsubaie FS; Madani AN
    Dermatol Ther; 2022 Jun; 35(6):e15452. PubMed ID: 35293657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and Safety of COVID-19 Vaccinations: An Umbrella Meta-Analysis.
    Jiesisibieke ZL; Liu WY; Yang YP; Chien CW; Tung TH
    Int J Public Health; 2023; 68():1605526. PubMed ID: 37485047
    [No Abstract]   [Full Text] [Related]  

  • 30. Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria.
    Osibogun AO; Shuaib FM; Adeyeye CM; Onajole AT; Ejembi CL; Banwat ME; Wright KO; Mohammed A; Adeleye OA; Yahya SJ; Ifeadike CO; Elemuwa UU; Bassey BE; Oluwole EO; Erinoso OA
    Niger Postgrad Med J; 2023; 30(1):18-24. PubMed ID: 36814159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.
    Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I
    Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy.
    Paolino G; Caputo V; Schroeder J; Marzano AV; Bonoldi E; Moltrasio C; Maronese CA; Borgonovo L; Rongioletti F
    Clin Dermatol; 2023; 41(2):312-319. PubMed ID: 36863621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
    Gambichler T; Boms S; Susok L; Dickel H; Finis C; Abu Rached N; Barras M; Stücker M; Kasakovski D
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):172-180. PubMed ID: 34661927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.
    Abdelmaksoud A; Wollina U; Temiz SA; Hasan A
    Dermatol Ther; 2022 Jun; 35(6):e15458. PubMed ID: 35306713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events following COVID-19 vaccination: A systematic review and meta-analysis.
    Kouhpayeh H; Ansari H
    Int Immunopharmacol; 2022 Aug; 109():108906. PubMed ID: 35671640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.